ClinicalTrials.Veeva

Menu

Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism (CHIPS)

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Venous Thromboembolism

Study type

Observational

Funder types

Other

Identifiers

NCT04477564
NIMAO/2020-01/SB-01

Details and patient eligibility

About

The aim of the study is to investigate the existence of clonal hematopoiesis of indeterminate potential (CHIP) in patients with a history of venous thromboembolism.

The study investigators make the assumption that these patients present mutations involved in CHIP occurrence.

Enrollment

150 patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men and women over 50 years old who have consulted at the Hematology laboratory of the Nîmes University Hospital for the occurrence or history of venous thromboembolism
  • Patient who has accepted that their DNA was kept and used in the context of research on venous thromboembolism (biobank (registration number DC-2008-290 and authorization number AC-2008-107))

Exclusion criteria

  • Patients less than 50 years old
  • Patient who has refused that their DNA was kept and used in the context of research on venous thromboembolism

Trial design

150 participants in 3 patient groups

Unprovoked proximal deep vein thrombosis
Provoked distal deep vein thrombosis
age-matched control group with no history of vein thrombosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems